@ageminute5
Active 7 months, 2 weeks ago
BACKGROUND Individuals with Down syndrome are likely to develop clinical and neuropathological brain changes resembling Alzheimer’s disease dementia by the ages of 35-40 years. Intranasal insulin is a potential treatment for neurodegenerative disease that has been shown to reduce amyloid plaque burden and improve verbal memory performance in […] View
Sorry, there was no activity found. Please try a different filter.